|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 49/18 | |||
| A61K 33/24 | |||
| A61K 49/04 | |||
| A61K 51/12 | |||
| A61K 38/18 | |||
| A61K 48/00 |
| (11) | Number of the document | 2019683 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07761286.9 |
| Date of filing the European patent application | 2007-04-25 | |
| (97) | Date of publication of the European application | 2009-02-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/067423 |
| Date | 2007-04-25 |
| (87) | Number | WO 2007/127803 |
| Date | 2007-11-08 |
| (30) | Number | Date | Country code |
| 795012 P | 2006-04-25 | US |
| (72) |
BANKIEWICZ, Krystof, S., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS |
| ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS |